Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares


Print article Print article
Refer this article Refer to a friend
© Business Wire 2008
2008-08-11 23:49:03 -

- BEL FUSE INC. (NASDAQ:BELFA) & (NASDAQ:BELFB) today announced that its Board of Directors has declared regular quarterly cash dividends of $0.06 per share on the Company's Class A common shares and $0.07 per share on the Company's Class B common shares.

Cash dividends for Class A and Class B common shares are payable on November 3, 2008 to

shareholders of record on October 15, 2008.

Bel currently has approximately 11,600,000 common shares outstanding, of which 2,200,000 are Class A common shares and 9,400,000 are Class B common shares.

About Bel

Bel (www.belfuse.com) and its subsidiaries are primarily engaged in the design, manufacture and sale of products used in networking, telecommunications, high speed data transmission, and consumer electronics. Products include magnetics (discrete components, power transformers and MagJack(R)s), modules (DC-DC converters, integrated analog front end modules and custom designs), circuit protection (miniature, micro and surface mount fuses) and interconnect devices (passive jacks, plugs and cable assemblies). Bel operates facilities around the world.

Investor Contact:
Neil Berkman Associates
310-826-5051
info@berkmanassociates.com
or
Company Contact:
Bel Fuse Inc.
Daniel Bernstein, President
ir@BelFuse.com


Disclaimer: (c) 2009 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com